Lv4
531 积分 2023-06-21 加入
Diabetes Mellitus and APOL1 Genotype Increase the Risk for Chronic Kidney Disease Progression in Sickle Cell Disease
6个月前
已完结
Has APOL1 kidney disease treatment been hiding in plain sight?
6个月前
已关闭
Successful management of camrelizumab-induced immune-checkpoint-inhibitors-related myocarditis
11个月前
已完结
A 67-Year-Old Man with Grade 3 Reactive Cutaneous Capillary Endothelial Proliferation Induced by Camrelizumab First Manifested in the Oral Mucosa – A Case Report
11个月前
已完结
皖公网安备34019202002308
